Sarim Khan
About Sarim Khan
Sarim Khan is a Co-Founder of Triomics, where he has worked since 2021. He previously held positions as General Secretary of Academic Affairs at the Indian Institute of Technology, Roorkee, and as a Biotech Researcher at the Massachusetts Institute of Technology.
Work at Triomics
Sarim Khan serves as a Co-Founder at Triomics, a position he has held since 2021. Based in the San Francisco Bay Area, he is involved in the development and implementation of innovative AI solutions for oncology research. One of his notable contributions is the creation of 'Triomics OncoLLM', an AI tool aimed at improving data efficiency and safety in oncology studies. Under his leadership, Triomics collaborates with several leading cancer centers across the United States to enhance research capabilities through advanced AI technology.
Education and Expertise
Sarim Khan completed his Bachelor's degree in Chemical Engineering at the Indian Institute of Technology, Roorkee. His academic background provides a strong foundation for his work in biotechnology and AI applications in healthcare. His education has equipped him with the technical knowledge necessary to navigate complex challenges in oncology research and data management.
Background
Before co-founding Triomics, Sarim Khan held the position of General Secretary for Academic Affairs (UG) at the Indian Institute of Technology, Roorkee from 2018 to 2019. He also worked as a Biotech Researcher at the Massachusetts Institute of Technology for 11 months, from 2019 to 2020. This diverse experience in academic leadership and research has contributed to his expertise in the field of biotechnology and AI.
Achievements
Sarim Khan has made significant contributions to oncology research through his work at Triomics. He developed 'Triomics OncoLLM', an AI tool that enhances data efficiency and safety in oncology research. His efforts in collaborating with leading cancer centers in the United States aim to advance the application of AI technology in cancer research, reflecting his commitment to improving healthcare outcomes.